What Levonorgestrel Treats: Main Uses and Benefits

Levonorgestrel is commonly used across domains where additional symptomatic support is needed following a disruptive event or situation. It is primarily relevant in contexts marked by increased discomfort or tension associated with acute, unplanned situations.

Supporting Management for Acute Symptomatic Events

The medicine is applied in contexts marked by increased discomfort or tension associated with unplanned or high-risk situations. This use is relevant when short-term symptom management is appropriate, and may contribute to easing the overall symptom load during periods of heightened concern.

Providing Time-Sensitive Assistance in Symptom Management

The medication is applied in clinical settings that involve acute or unstable symptom patterns where timing is a critical factor for supportive management. It is often used during phases when symptoms become more noticeable and short-term symptomatic assistance is needed. Using this option assists with maintaining functional stability during episodes of heightened discomfort.

Quick Fact: Support for Stability Levonorgestrel contributes to improved day-to-day comfort during symptomatic periods and helps maintain a sense of stability when symptoms are more noticeable.

Levonorgestrel is a progestin used primarily in hormonal contraceptives, including emergency contraceptive pills, birth control pills, and intrauterine systems (IUS). Its suitability depends on the specific formulation and dose.

Who Can Generally Use Levonorgestrel

Most healthy individuals who require contraception can use levonorgestrel-containing products. For emergency contraception, it is a suitable option for most women who need to prevent pregnancy after unprotected intercourse, ideally taken as soon as possible. For long-term contraception, it is a widely used and highly effective option.

---

Who Cannot Use Levonorgestrel

Levonorgestrel is generally contraindicated in individuals with:

• Known or suspected pregnancy: It is not an abortion pill and is not used to terminate an existing pregnancy.
• Unexplained abnormal vaginal bleeding.
• Hypersensitivity to levonorgestrel or any component of the formulation.

Specific formulations, especially combined oral contraceptives (which also contain estrogen) and certain doses, may have additional contraindications related to liver disease, blood clot history, or certain cancers. For the levonorgestrel-only emergency pill, specific contraindications are limited, but caution is advised in cases of severe malabsorption syndromes, such as Crohn’s disease, that may reduce efficacy. Always consult a healthcare provider to determine the safest and most appropriate contraceptive method.

Interactions with other medicines and products

The principal drug interaction concern with levonorgestrel is the risk of decreased effectiveness when co-administered with medicines or herbal products that induce metabolic enzymes in the liver. This effect is primarily due to the induction of Cytochrome P450 3A4 (CYP3A4), which increases the clearance and significantly reduces the plasma concentration of levonorgestrel.

Drugs and herbal products documented to induce these enzymes include: Barbiturates, Phenytoin, Carbamazepine, Griseofulvin, Rifampicin, and the herbal supplement St. John's wort (Hypericum perforatum). Certain HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors, such as Ritonavir and Efavirenz, also exhibit this potential. For instance, Efavirenz has been shown to reduce levonorgestrel levels by approximately 50%.

Co-administration with any known enzyme-inducing agent may compromise the contraceptive efficacy of levonorgestrel. Patients should be advised to consult the labeling of all concurrently used medications to obtain information regarding interactions with progestin-only pills or their potential for enzyme induction. Furthermore, if vomiting occurs within two hours of taking the tablet, the dose may need to be repeated.

Levonorgestrel functions as a synthetic progestin and a high-affinity agonist for the progesterone receptor (PR), primarily targeting reproductive tissues, including the hypothalamus, pituitary gland, and ovaries. The molecule enters target cells and binds to the intracellular PR, forming a ligand-receptor complex that translocates to the nucleus. This complex binds to Progesterone Response Elements (PREs) on DNA, thereby modulating the transcription of specific genes.

At the level of the hypothalamic-pituitary-ovarian (HPO) axis, Levonorgestrel's action on the PR in the hypothalamus and pituitary inhibits the pulsatile secretion of Gonadotropin-Releasing Hormone (GnRH) and subsequent pituitary release of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH). This negative feedback suppresses follicular development and specifically prevents the LH surge, which is the required signal for ovulation.

Additionally, Levonorgestrel acts on the endometrium, inducing early secretory transformation and glandular atrophy. It also modulates the cervical mucus, increasing its viscosity and reducing its volume due to direct interaction with PRs in the cervical crypts.

These effects modulate the physiological state of the reproductive system.

How to Use Levonorgestrel

The usage of Levonorgestrel is defined by its two primary forms: the Oral Tablet (for emergency contraception) and the Intrauterine System (IUS) for long-term control. Administration is defined by standardized clinical and regulatory protocols.

---

Official Administration and Dosing

Administration Component	Oral Tablet (Emergency Contraception)	Intrauterine System (IUS)
Route of Administration	Oral	Intrauterine
Standard Dosing Regimen	A single dose of 1.5 mg or two 0.75 mg doses taken 12 hours apart.	One device inserted into the uterine cavity, releasing Levonorgestrel continuously.
Timing Constraint	Must be taken as soon as possible within 72 hours (3 days) of unprotected intercourse.	Insertion time varies, often postpartum or during the menstrual cycle.
Frequency Pattern	A single course of treatment. The tablet is not for routine use.	Long-term use (e.g., 3 to 8 years, depending on the specific device).

---

Procedural and Contextual Instructions

Standard labeling outlines specific procedural conditions for proper use:

• Vomiting Rule: If the oral tablet is taken and vomiting occurs within two hours, the need for a repeat dose may be indicated.
• Enzyme Inducers: For individuals taking certain hepatic enzyme-inducing medicines, consideration may be given to a double dose (total 3 mg) of the oral emergency contraceptive.
• IUS Insertion: This device requires insertion by a trained healthcare provider using an aseptic technique in a clinical setting.

These directives define the standardized application of Levonorgestrel, outlining not only the dose and route but also the essential, time-sensitive and conditional steps required for its use.

Research Evidence / Overview of Studies for Levonorgestrel

---

Evidence for Use in Emergency Contraception

Levonorgestrel was studied for use as an emergency contraceptive. Research primarily includes comparative clinical trials (known as RCTs) and studies that combine the findings of multiple trials (known as meta-analyses). Researchers examined how the timing of taking the medication was associated with the measured outcome of pregnancy prevention. Findings indicate that use following an acute episode was associated with differences in the likelihood of pregnancy documented in some studies.

Uncertainty remains regarding the effects across a wide range of body weights; some studies suggest that the measured outcome may be influenced by an individual's weight or body mass index (BMI), but data for certain groups remain insufficient.

---

Evidence for Use in Long-Term Reversible Contraception

Long-term use of levonorgestrel delivered through an intrauterine system (IUS) was studied for its role in preventing pregnancy over several years. The evidence base includes long-term observational cohort studies and comparative trials. The research describes the documentation of the primary measured outcome, pregnancy prevention, over the designated period of use, with studies reporting measurements of continuous use for up to several years.

Follow-up durations were limited primarily to the period the device is approved to remain in place. Data for certain groups, such as very young adolescents or those with pre-existing complex gynecological conditions not typically included in trials, remain insufficient.

---

What Is Still Uncertain About Levonorgestrel

Despite extensive research, certainty remains low in several areas. Evidence quality varies across studies, especially between high-quality RCTs and lower-quality observational data. Findings were mixed regarding the influence of different body weights on the measured outcome of the oral emergency contraceptive dose. Comparative evidence is lacking in head-to-head trials against every other available alternative for both the emergency and long-term uses. The results apply only to the populations studied, meaning the applicability to individuals who fall outside the typical trial parameters is not well characterized, and research is ongoing to address these gaps.

Common questions about Levonorgestrel (FAQ)

Q: What is levonorgestrel?

Levonorgestrel is a synthetic hormone, specifically a progestin, that is primarily used as a form of contraception.

It is structurally similar to progesterone, a naturally occurring hormone in the body.

---

Q: How does levonorgestrel work as a form of contraception?

Levonorgestrel primarily works to prevent pregnancy by:

• Preventing ovulation (the release of an egg from the ovary).
• Thickening the cervical mucus, which makes it harder for sperm to reach the egg.
• Altering the lining of the uterus, which may prevent implantation of a fertilized egg.

Its effectiveness depends on the formulation and timing of use (e.g., daily pill versus emergency contraceptive).

---

Q: What are the different ways levonorgestrel is used?

Levonorgestrel is available in several forms, most commonly for contraception:

• Oral Contraceptive Pills (OCPs): Used daily as a primary form of birth control.
• Emergency Contraceptive Pills (ECPs): A higher dose taken within a short window after unprotected intercourse (often called the "morning-after pill").
• Intrauterine Devices (IUDs): Small, T-shaped devices placed in the uterus that slowly release levonorgestrel over several years for long-acting reversible contraception.
• Subdermal Implants: Small rods placed under the skin that release the hormone for up to several years.

---

Q: Can levonorgestrel affect a menstrual period?

Yes, levonorgestrel can affect the menstrual cycle. This effect varies depending on the type of formulation used:

• Daily Oral Pills: Typically lead to regular, lighter, and less painful periods.
• Emergency Contraception: May cause the next period to be lighter, heavier, earlier, or later than usual.
• IUDs and Implants: Often lead to irregular bleeding or spotting, especially in the first few months. Many people using levonorgestrel IUDs or implants experience very light bleeding or may stop having periods entirely after the first year.

If a period is delayed significantly after using emergency contraception, a pregnancy test may be recommended.

---

Q: Are there common side effects of using levonorgestrel?

Common side effects can vary by the type of product. For oral pills and emergency contraception, common temporary side effects may include:

• Nausea or vomiting
• Headache
• Dizziness or fatigue
• Breast tenderness
• Irregular bleeding or spotting

For IUDs, side effects may also include cramping or back pain. These side effects usually lessen over time as the body adjusts to the hormone.

---

Q: Does levonorgestrel protect against sexually transmitted infections (STIs)?

No, levonorgestrel products do not protect against sexually transmitted infections (STIs), including HIV/AIDS.

Only barrier methods, such as condoms, are effective in reducing the risk of STI transmission. Contraceptives containing levonorgestrel are only designed to prevent pregnancy.

---

Q: Does taking the levonorgestrel emergency contraceptive pill cause an abortion?

No. Levonorgestrel emergency contraceptive pills are not the same as the abortion pill (mifepristone).

The levonorgestrel emergency contraceptive pill works by preventing pregnancy from occurring, primarily by stopping or delaying ovulation. It is not effective if a woman is already pregnant, nor will it interrupt an existing pregnancy.

How to Store and Dispose of Levonorgestrel?

Levonorgestrel should be stored at room temperature, typically between 68 F and 77 F (20 C and 25 C). Keep the medication in the original container, tightly closed, and out of the reach of children. Avoid storing it in areas exposed to excessive heat or moisture, such as bathrooms.

Check the expiration date on the packaging and discard any medication that is past this date.

---

Disposal Guidelines

• Do not flush levonorgestrel down the toilet or pour it down a drain unless specifically instructed to do so by a healthcare provider or drug take-back program.
• The best way to dispose of this medication is through a local drug take-back program. Check with your pharmacist or local waste disposal company for information on these programs.
• If a take-back program is unavailable, you may dispose of the medication by mixing it with an undesirable substance, such as dirt or used coffee grounds. Place the mixture in a sealed plastic bag or container and throw it in the trash. Ensure the original packaging is removed or obscured to protect privacy.